These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 8382323
1. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response. Yanagihara Y, Kiniwa M, Ikizawa K, Shida T, Matsuura N, Koda A. Jpn J Pharmacol; 1993 Jan; 61(1):31-9. PubMed ID: 8382323 [Abstract] [Full Text] [Related]
2. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1). Regulation of murine IgE response. Yanagihara Y, Kiniwa M, Ikizawa K, Yamaya H, Shida T, Matsuura N, Koda A. Jpn J Pharmacol; 1993 Jan; 61(1):23-30. PubMed ID: 8382322 [Abstract] [Full Text] [Related]
3. IPD-1151T: a prototype drug for IgE antibody synthesis modulation. Koda A, Yanagihara Y, Matsuura N. Agents Actions Suppl; 1991 Jan; 34():369-78. PubMed ID: 1665310 [Abstract] [Full Text] [Related]
4. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines. Oda N, Minoguchi K, Yokoe T, Hashimoto T, Wada K, Miyamoto M, Tanaka A, Kohno Y, Adachi M. Life Sci; 1999 Jan; 65(8):763-70. PubMed ID: 10466742 [Abstract] [Full Text] [Related]
5. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp. Asano K, Mizutani T, Shimane T, Hisano M, Hisamitsu T, Suzaki H. Mediators Inflamm; 2000 Jan; 9(2):77-84. PubMed ID: 10958380 [Abstract] [Full Text] [Related]
7. Allergen-specific human IgE helper T cell lines derived from patients allergic to Japanese cedar pollen. Yanagihara Y, Kiniwa M, Koshio T, Kajiwara K, Yasueda H, Ikizawa K. Int Arch Allergy Immunol; 1994 Oct; 105(2):162-70. PubMed ID: 7920016 [Abstract] [Full Text] [Related]
8. [Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions]. Matsuura N, Mori H, Nagai H, Koda A. Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):495-501. PubMed ID: 1282894 [Abstract] [Full Text] [Related]
9. [Inhibitory effect of IPD-1151T (suplatast tosilate) on mast cell induction from normal mouse spleen cells]. Kouno S, Adachi M, Asano K, Okamoto K, Takahashi T. Arerugi; 1992 Oct; 41(10):1488-91. PubMed ID: 1336362 [Abstract] [Full Text] [Related]
10. [Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice]. Matsuura N, Mori H, Nagai H, Koda A. Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):485-93. PubMed ID: 1336470 [Abstract] [Full Text] [Related]
11. IPD-1151T (suplatast tosilate) inhibits interleukin (IL)-13 release but not IL-4 release from basophils. Shichijo M, Shimizu Y, Hiramatsu K, Togawa M, Inagaki N, Takagi K, Nagai H. Jpn J Pharmacol; 1999 Apr; 79(4):501-4. PubMed ID: 10361893 [Abstract] [Full Text] [Related]
12. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma. Prinz JC, Baur X, Mazur G, Rieber EP. Eur J Immunol; 1990 Jun; 20(6):1259-64. PubMed ID: 2142456 [Abstract] [Full Text] [Related]
13. Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes. Konno S, Adachi M, Asano K, Gonogami Y, Ikeda K, Okamoto K, Takahashi T. Eur J Pharmacol; 1994 Jun 23; 259(1):15-20. PubMed ID: 7957588 [Abstract] [Full Text] [Related]
14. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice. Konno S, Asano K, Gonokami Y, Kurokawa M, Kawazu K, Adachi M. Arerugi; 1995 May 23; 44(5):556-61. PubMed ID: 7619009 [Abstract] [Full Text] [Related]
15. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo. Kurokawa M, Kawazu K, Asano K, Fumio K, Mita A, Adachi M. Mediators Inflamm; 2001 Dec 23; 10(6):333-7. PubMed ID: 11817674 [Abstract] [Full Text] [Related]
16. The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells. Hsu LW, Yang CH, Goto S, Nakano T, Lai CY, Lin YC, Kao YH, Chen SH, Cheng YF, Jawan B, Chiu KW, Tsao FK, Chen CL. Transpl Immunol; 2007 Nov 23; 18(2):108-14. PubMed ID: 18005853 [Abstract] [Full Text] [Related]
17. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate. Woerly G, Decot V, Loiseau S, Loyens M, Chihara J, Ono N, Capron M. Clin Exp Allergy; 2004 Sep 23; 34(9):1379-87. PubMed ID: 15347370 [Abstract] [Full Text] [Related]
18. Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T). Tsukagoshi H, Nagashima M, Horie T, Oyama T, Yoshii A, Sato T, Iizuka K, Dobashi K, Mori M. Intern Med; 1998 Dec 23; 37(12):1064-7. PubMed ID: 9932643 [Abstract] [Full Text] [Related]
19. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T. Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. J Urol; 2000 Dec 23; 164(6):1917-20. PubMed ID: 11061880 [Abstract] [Full Text] [Related]
20. Effects of IL-4 and IL-13 on total and allergen specific IgE production by cultured PBMC from allergic patients determined with recombinant pollen allergens. Dolecek C, Steinberger P, Susani M, Kraft D, Valenta R, Boltz-Nitulescu G. Clin Exp Allergy; 1995 Sep 23; 25(9):879-89. PubMed ID: 8564727 [Abstract] [Full Text] [Related] Page: [Next] [New Search]